Monroe Capital Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Monroe Capital in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Monroe Capital stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MRCC, but not buy additional shares or sell existing shares.
View analyst ratings for Monroe Capital or view top-rated stocks.

Wall Street analysts have given Monroe Capital a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Monroe Capital wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Monroe Capital is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Monroe Capital.

Monroe Capital Co. (NASDAQ:MRCC) announced its quarterly earnings data on Monday, August, 2nd. The financial services provider reported $0.25 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.25. Monroe Capital had a trailing twelve-month return on equity of 9.18% and a net margin of 82.79%.
View Monroe Capital's earnings history.

Monroe Capital's stock was trading at $9.27 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MRCC stock has increased by 10.4% and is now trading at $10.23.
View which stocks have been most impacted by COVID-19.

Monroe Capital announced a quarterly dividend on Thursday, September 2nd. Investors of record on Thursday, September 16th will be given a dividend of $0.25 per share on Thursday, September 30th. This represents a $1.00 annualized dividend and a dividend yield of 9.78%. The ex-dividend date is Wednesday, September 15th.
View Monroe Capital's dividend history.

Monroe Capital pays an annual dividend of $1.00 per share and currently has a dividend yield of 9.51%. MRCC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Monroe Capital does not yet have a strong track record of dividend growth. The dividend payout ratio of Monroe Capital is 68.03%. This payout ratio is at a healthy, sustainable level, below 75%. Based on EPS estimates, Monroe Capital will have a dividend payout ratio of 100.00% in the coming year. This indicates that Monroe Capital may not be able to sustain their current dividend.
View Monroe Capital's dividend history.

Some companies that are related to Monroe Capital include Patria Investments (PAX), Vinci Partners Investments (VINP), Pzena Investment Management (PZN), Diamond Hill Investment Group (DHIL), Blue Owl Capital (OWL), Barings BDC (BBDC), Fidus Investment (FDUS), Bridge Investment Group (BRDG), Puyi (PUYI), Value Line (VALU), Saratoga Investment (SAR), Silvercrest Asset Management Group (SAMG), Hywin (HYW), Manning & Napier (MN) and Westwood Holdings Group (WHG).
View all of MRCC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Monroe Capital investors own include Energy Transfer (ET), New Residential Investment (NRZ), Enterprise Products Partners (EPD), Intelsat (I), Annaly Capital Management (NLY), Ares Capital (ARCC), AGNC Investment (AGNC), AMC Entertainment (AMC), NGL Energy Partners (NGL) and TriplePoint Venture Growth BDC (TPVG).

Monroe Capital trades on the NASDAQ under the ticker symbol "MRCC."

Monroe Capital's stock is owned by many different institutional and retail investors. Top institutional investors include Advisor Group Holdings Inc. (3.98%), Cliffwater LLC (2.42%), Blair William & Co. IL (2.23%), Envestnet Asset Management Inc. (0.93%), Advisors Asset Management Inc. (0.72%) and Commonwealth Equity Services LLC (0.62%). Company insiders that own Monroe Capital stock include Aaron Daniel Peck, Jeffrey D Steele and Theodore L Koenig.
View institutional ownership trends for Monroe Capital.

MRCC stock was sold by a variety of institutional investors in the last quarter, including Cliffwater LLC, Blair William & Co. IL, California Public Employees Retirement System, Mercer Global Advisors Inc. ADV, Freestone Capital Holdings LLC, Commonwealth Equity Services LLC, Chicago Partners Investment Group LLC, and Susquehanna International Group LLP.
View insider buying and selling activity for Monroe Capital or view top insider-selling stocks.

MRCC stock was bought by a variety of institutional investors in the last quarter, including Mackenzie Financial Corp, Envestnet Asset Management Inc., Wealthstar Advisors LLC, Fiduciary Group LLC, Advisor Group Holdings Inc., Advisors Asset Management Inc., LPL Financial LLC, and Virtus ETF Advisers LLC. Company insiders that have bought Monroe Capital stock in the last two years include Aaron Daniel Peck, Jeffrey D Steele, and Theodore L Koenig.
View insider buying and selling activity for Monroe Capital or or view top insider-buying stocks.

Shares of MRCC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MRCC stock can currently be purchased for approximately $10.23.

Monroe Capital has a market capitalization of $220.40 million and generates $61.58 million in revenue each year. The financial services provider earns $1.65 million in net income (profit) each year or $1.47 on an earnings per share basis.

The official website for Monroe Capital is www.monroebdc.com.

Monroe Capital is headquartered at 311 SOUTH WACKER DRIVE SUITE 6400, CHICAGO IL, 60606.

Monroe Capital's mailing address is 311 SOUTH WACKER DRIVE SUITE 6400, CHICAGO IL, 60606. The financial services provider can be reached via phone at (312) 258-8300 or via email at [email protected].